Skip to content

Multicenter Study of the Avenue L Interbody Spinal Fusion System Using VerteBRIDGE Plating and Posterior Fixation

A Prospective, Multicenter, Open Label Clinical Study of the Safety andEfficacy of the Avenue L Interbody Spinal Fusion System Using the VerteBRIDGE Plating System and Supplemental Posterior Fixation

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02068768
Enrollment
13
Registered
2014-02-21
Start date
2013-07-15
Completion date
2016-03-23
Last updated
2019-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative Disc Disease

Keywords

fusion, lateral interbody fusion system, lumbar spine, degenerative disc disease

Brief summary

The purpose of this prospective clinical study is to examine the short-term safety and efficacy of the Avenue®- L interbody Spinal Fusion System with VerteBRIDGE® plating to treat one and two level degenerative disc disease between L2 and S1 with a focus on fusion rate.

Interventions

DEVICEAvenue® L Interbody Fusion System (LDR Spine)

PEEK, intervertebral cage for interbody fusion of the lumbar spine

Sponsors

LDR Spine USA
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects must be candidates for on-label use of the Avenue L device (have degenerative disc disease, use only at one or two contiguous levels, posterior fixation must be used, autograft must be used in the interbody cage) * Subject must be skeletally mature at the time of surgery, i.e. the subject must be at least 21 years of age at the time of surgery * Subject should have had a minimum of 6 months of non-operative treatment prior to surgery * The placement of the Avenue L device must be a primary surgery * Subject must be willing to sign the consent form and be able to return for all follow up visits.

Exclusion criteria

* Subject must not have had prior surgery at the operative level(s) * Subject is known to have substance or alcohol addictions * Subject has lateral curvature of the spine (scoliosis, all types) * Subject is a prisoner * Subject is pregnant * Subject has an active infection or sepsis at the time of surgery * Subject has any neuromuscular disorder that would preclude accurate neurologic evaluations

Design outcomes

Primary

MeasureTime frameDescription
Fusion Rate12 months after device implantationNumber of participants with fused disc space as measured radiographically

Secondary

MeasureTime frameDescription
Mean Oswestry Disability Index (ODI)preop, 3 mo, 6 mo, 12 mo post opThe Oswestry Disability Index (ODI) is an index derived from the Oswestry Low Back Pain Questionnaire used by clinicians and researchers to quantify disability for low back pain. Each question is scored on a scale of 0-5 with the first statement being zero and indicating the least amount of disability and the last statement is scored 5 indicating most severe disability.The scores for all questions answered are summed, then multiplied by two to obtain the index (range 0 to 100). Zero is equated with no disability and 100 is the maximum disability possible.
Visual Analog Scale (VAS) of Back Painpreop, 3 mo, 6 mo, 12 moThe pain VAS is a continuous scale comprised of a horizontal line 10 centimeters in length, anchored by 2 verbal descriptors, one for each symptom extreme of either no pain or worst imaginable pain. The pain VAS is self-completed by the respondent. The respondent is asked to place a line perpendicular to the VAS line at the point that represents their pain intensity. The score is determined by measuring the distance (mm) on the 10-cm line between the no pain anchor and the patient's mark, providing a range of scores from 0-100.

Countries

United States

Participant flow

Participants by arm

ArmCount
Operated Subjects
Subjects scheduled to receive an Avenue® L Interbody Fusion System (LDR Spine) for fusion of the lumbar spine from L2-S1 Avenue® L Interbody Fusion System (LDR Spine): PEEK, intervertebral cage for interbody fusion of the lumbar spine
13
Total13

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyEarly Termination by Sponsor2
Overall StudyLost to Follow-up5

Baseline characteristics

CharacteristicOperated Subjects
Age, Continuous54.5 Years
BMI (kg/m^2)31.5 kg/m^2
Previous Lumbar Surgery4 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
1 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
12 Participants
Region of Enrollment
United States
13 participants
Sex: Female, Male
Female
6 Participants
Sex: Female, Male
Male
7 Participants
Surgical Level
L2-L3
3 Participants
Surgical Level
L2-L4
1 Participants
Surgical Level
L3-L4
3 Participants
Surgical Level
L4-L5
6 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 13
other
Total, other adverse events
6 / 13
serious
Total, serious adverse events
0 / 13

Outcome results

Primary

Fusion Rate

Number of participants with fused disc space as measured radiographically

Time frame: 12 months after device implantation

Population: Poor enrollment led to early termination and low number of participants available for analysis. Data were available for 13 participants preoperatively, 12 at 3 months, 8 at 6 months, and 6 at 12 months. Only 3 of 6 participants reaching 12 month follow up had radiographs available for analysis.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Operated SubjectsFusion Rate3 Participants
Secondary

Mean Oswestry Disability Index (ODI)

The Oswestry Disability Index (ODI) is an index derived from the Oswestry Low Back Pain Questionnaire used by clinicians and researchers to quantify disability for low back pain. Each question is scored on a scale of 0-5 with the first statement being zero and indicating the least amount of disability and the last statement is scored 5 indicating most severe disability.The scores for all questions answered are summed, then multiplied by two to obtain the index (range 0 to 100). Zero is equated with no disability and 100 is the maximum disability possible.

Time frame: preop, 3 mo, 6 mo, 12 mo post op

Population: Data were available for 13 participants preoperatively, 12 at 3 months, 8 at 6 months, and 6 at 12 months

ArmMeasureGroupValue (MEAN)
Operated SubjectsMean Oswestry Disability Index (ODI)Preop53 score on a scale
Operated SubjectsMean Oswestry Disability Index (ODI)3 months46 score on a scale
Operated SubjectsMean Oswestry Disability Index (ODI)6 months45 score on a scale
Operated SubjectsMean Oswestry Disability Index (ODI)12 months37 score on a scale
Secondary

Visual Analog Scale (VAS) of Back Pain

The pain VAS is a continuous scale comprised of a horizontal line 10 centimeters in length, anchored by 2 verbal descriptors, one for each symptom extreme of either no pain or worst imaginable pain. The pain VAS is self-completed by the respondent. The respondent is asked to place a line perpendicular to the VAS line at the point that represents their pain intensity. The score is determined by measuring the distance (mm) on the 10-cm line between the no pain anchor and the patient's mark, providing a range of scores from 0-100.

Time frame: preop, 3 mo, 6 mo, 12 mo

Population: Data were available for 13 participants preoperatively, 12 at 3 months, 8 at 6 months, and 6 at 12 months

ArmMeasureGroupValue (MEAN)
Operated SubjectsVisual Analog Scale (VAS) of Back PainPreop77 units on a scale
Operated SubjectsVisual Analog Scale (VAS) of Back Pain3 months42 units on a scale
Operated SubjectsVisual Analog Scale (VAS) of Back Pain6 months29 units on a scale
Operated SubjectsVisual Analog Scale (VAS) of Back Pain12 months23 units on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026